(Q41440241)

30 September 2017

1 reference

title

Post-transplant diabetes mellitus. The role of immunosuppression (English)

1 reference

30 September 2017

1 reference

R M Jindal

1

1 reference

30 September 2017

R A Sidner

series ordinal

2

1 reference

30 September 2017

M L Milgrom

series ordinal

3

1 reference

30 September 2017

language of work or name

1 reference

1 April 1997

1 reference

30 September 2017

1 reference

30 September 2017

volume

16

1 reference

30 September 2017

issue

4

1 reference

30 September 2017

page(s)

242-257

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199716040-00002

30 September 2017

exact match

0 references

cites work

Effect of FK 506 on function of human islets of Langerhans

1 reference

12 December 2020

The efficacy and toxicity of rapamycin in murine islet transplantation. In vitro and in vivo studies

1 reference

12 December 2020

Pancreatic islet transplantation in cynomolgus monkeys. Initial studies and evidence that cyclosporine impairs glucose tolerance in normal monkeys.

1 reference

12 December 2020

Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss.

1 reference

12 December 2020

Beneficial metabolic impact of the novel immunosuppressant rapamycin in chronic canine islet autograft recipients

1 reference

12 December 2020

Microchimerism, dendritic cell progenitors and transplantation tolerance

1 reference

12 December 2020

Clinical characteristics and possible risk factors in postrenal transplant diabetes mellitus

1 reference

12 December 2020

Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506).

1 reference

12 December 2020

RS-61443 allows islet allografting and specific tolerance induction in adult mice

1 reference

12 December 2020

Mechanism of FK506-induced glucose intolerance in rats

1 reference

12 December 2020

Endocrine and metabolic disorders following kidney transplantation

1 reference

12 December 2020

Renal transplantation in baboons under FK 506

1 reference

12 December 2020

Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients

1 reference

12 December 2020

The incidence of subsequent acute rejection following the treatment of refractory renal allograft rejection with mycophenolate mofetil (RS61443)

1 reference

12 December 2020

The in vivo and in vitro effect of 15-deoxyspergualin on pancreatic islet function

1 reference

12 December 2020

New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients

1 reference

12 December 2020

Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model

1 reference

12 December 2020

Comparison of the effects of the immunosuppressive agents FK 506 and cyclosporin A on rat kidney mitochondria.

1 reference

12 December 2020

The effect of rapamycin on kidney function in the Sprague-Dawley rat.

1 reference

12 December 2020

Post-renal transplant diabetes mellitus--a retrospective study

1 reference

12 December 2020

Racial differences in the survival of cadaveric renal allografts. Overriding effects of HLA matching and socioeconomic factors

1 reference

12 December 2020

FK506-induced impairment of glucose metabolism in the primate--studies in pancreatic transplant recipients and in nontransplanted animals.

1 reference

12 December 2020

Effect of FK 506 on Spontaneous Diabetes in BB Rats

1 reference

12 December 2020

A prospective randomized trial of FK506-based immunosuppression after renal transplantation

1 reference

12 December 2020

Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group

1 reference

12 December 2020

Xenotransplantation of pig pancreatic islets to rat using 15-deoxyspergualin monotherapy

1 reference

12 December 2020

RS-61443--a new, potent immunosuppressive agent

1 reference

12 December 2020

Morphological and functional changes of islets of Langerhans in FK506-treated rats

1 reference

12 December 2020

A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine

1 reference

12 December 2020

Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action.

1 reference

12 December 2020

The effect of FK506 versus cyclosporine on glucose and lipid metabolism--a randomized trial

1 reference

12 December 2020

Possible role for calmodulin in insulin release. Studies with trifluoperazine in rat pancreatic islets

1 reference

12 December 2020

Rescue therapy with tacrolimus after combined kidney/pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity

1 reference

12 December 2020

One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group

1 reference

12 December 2020

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance

1 reference

12 December 2020

Deterioration in glucose metabolism in pancreatic transplant recipients after conversion from azathioprine to cyclosporine

1 reference

12 December 2020

A randomized prospective trial of steroid withdrawal after liver transplantation.

1 reference

12 December 2020

Inhibition by cyclosporine of insulin secretion--a beta cell-specific alteration of islet tissue function

1 reference

12 December 2020

Facilitation of specific tolerance induction in adult mice by RS-61443

1 reference

12 December 2020

The influence of ( +/- )-15-deoxyspergualin on revascularization of xenogeneic transplanted islets of Langerhans

1 reference

12 December 2020

Diabetes mellitus after renal transplantation in the cyclosporine era--an analysis of risk factors

1 reference

12 December 2020

Diabetes mellitus after renal transplantation: characteristics, outcome, and risk factors

1 reference

12 December 2020

Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy

1 reference

12 December 2020

Advantages of low dose steroid from the day after renal transplantation

1 reference

12 December 2020

Post-transplant diabetes mellitus and methylprednisolone pharmacokinetics in African-American and Caucasian renal transplant recipients

1 reference

12 December 2020

Effects of cyclosporin on insulin and C-peptide secretion in healthy beagles

1 reference

12 December 2020

Posttransplant diabetes mellitus--a review.

1 reference

12 December 2020

Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islets

1 reference

12 December 2020

Toxic effects of cyclosporine on the endocrine pancreas of Wistar rats

1 reference

12 December 2020

Glycosuria and hyperglycaemia after kidney transplantation

1 reference

12 December 2020

A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels.

1 reference

12 December 2020

Follow-up of cyclosporine-treated pediatric renal allograft recipients after cessation of prednisone

1 reference

12 December 2020

Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients

1 reference

12 December 2020

Trends in the use of glucocorticoids in renal transplantation

1 reference

12 December 2020

Long-term (24-month) follow-up of steroid withdrawal in renal allograft recipients with posttransplant diabetes mellitus

1 reference

12 December 2020

Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group

1 reference

12 December 2020

Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator

1 reference

12 December 2020

Prevention of insulitis and diabetes in nonobese diabetic mice by administration of FK506

1 reference

12 December 2020

Racial differences in the incidence of steroid diabetes in renal transplant patients

1 reference

12 December 2020

Insulin resistance and insulin deficiency in the pathogenesis of posttransplantation diabetes in man

1 reference

12 December 2020

Posttransplant diabetes in kidney transplant recipients.

1 reference

12 December 2020

Cyclosporin-induced inhibition of insulin secretion in isolated rat islets and HIT cells

1 reference

12 December 2020

Normal glucose metabolism and insulin secretion in CyA-treated nondiabetic renal allograft patients not receiving steroids.

1 reference

12 December 2020

Insulin independence in type I diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin

1 reference

12 December 2020

Long-term effects of cyclosporin A on cultured mouse pancreatic islets

1 reference

12 December 2020

Diabetogenic effects of FK506 on renal subcapsular islet isografts in rat

1 reference

12 December 2020

Contribution of insulin resistance to catabolic effect of prednisone on leucine metabolism in humans.

1 reference

12 December 2020

Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group

1 reference

12 December 2020

A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation

1 reference

12 December 2020

Successful withdrawal of corticosteroids in heart transplantation

1 reference

12 December 2020

Reversal of severe FK506 side effects by conversion to cyclosporine-based immunosuppression

1 reference

12 December 2020

The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients

1 reference

12 December 2020

Racial differences in the pharmacokinetics of methylprednisolone in black and white renal transplant recipients

1 reference

12 December 2020

Long-term consequences of different immunosuppressive regimens for renal allografts

1 reference

12 December 2020

Effects of cyclosporin on prednisolone metabolism

1 reference

12 December 2020

The effects of FK506 and cyclosporine on the exocrine function of the rat pancreas

1 reference

12 December 2020

Effect of deoxyspergualin on the endocrine function of the rat pancreas

1 reference

12 December 2020

The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation

1 reference

12 December 2020

Serum lipid changes in liver transplant recipients in a prospective trial of cyclosporine versus FK506

1 reference

12 December 2020

Deoxyspergualin--a novel immunosuppressant

1 reference

12 December 2020

Possible role for the glucose-fatty acid cycle in dexamethasone-induced insulin antagonism in rats

1 reference

12 December 2020

Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group

1 reference

12 December 2020

Some Characteristics of Steroid Diabetes: A Study in Renal-Transplant Recipients Receiving High-Dose Corticosteroid Therapy

1 reference

12 December 2020

Preclinical evaluation of a new potent immunosuppressive agent, rapamycin

1 reference

12 December 2020

The metabolic impact of rapamycin (sirolimus) in chronic canine islet graft recipients.

1 reference

12 December 2020

FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression

1 reference

12 December 2020

Reversibility of the acute toxic effect of cyclosporin A on pancreatic B cells of Wistar rats

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients

1 reference

12 December 2020

The effect of race on access and outcome in transplantation

1 reference

12 December 2020

Effects of (-)15-deoxyspergualin on pancreatic islet B-cell function in vitro and on the development of diabetes after multiple low dose streptozotocin administration

1 reference

12 December 2020

A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation

1 reference

12 December 2020

Adverse effects of FK 506 overdosage after liver transplantation

1 reference

12 December 2020

Association of HLA Antigens with Glucose Intolerance Following Renal Transplantation

1 reference

12 December 2020

Dysglycaemia and risk of cardiovascular disease

1 reference

12 December 2020

Glucocorticoid Inhibition of Glucose Uptake by Peripheral Tissues: Old and New Evidence, Molecular Mechanisms, and Physiological Significance

1 reference

12 December 2020

Role of cyclosporin A in macromolecular synthesis of beta-cells

1 reference

12 December 2020

FK-506 in experimental renal allografts.

1 reference

12 December 2020

Recovery and hypersecretion of insulin and reversal of insulin resistance after withdrawal of short-term cyclosporine treatment

1 reference

12 December 2020

HLA-A28 and steroid-induced diabetes in renal transplant patients.

1 reference

12 December 2020

Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression

1 reference

12 December 2020

Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell.

1 reference

12 December 2020

Weaning of immunosuppression in long-term liver transplant recipients

1 reference

12 December 2020

Effect of FK 506 on glucose metabolism and insulin secretion in normal rats

1 reference

12 December 2020

A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group

1 reference

12 December 2020

The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial

1 reference

12 December 2020

High incidence of post-transplant diabetes mellitus in a single-centre study

1 reference

12 December 2020

Effect of FK506 on insulin secretion in normal dogs

1 reference

12 December 2020

Metabolic control at two months to 4.5 years after pancreatic transplantation, with special reference to the role of cyclosporine

1 reference

12 December 2020

Effect of cyclosporine on the endocrine and exocrine pancreas in kidney transplant recipients

1 reference

12 December 2020

Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group

1 reference

12 December 2020

The role of cell migration and microchimerism in the induction of tolerance after solid organ transplantation

1 reference

12 December 2020

Alterations in Insulin Binding Induced by Changes in Vivo in the Levels of Glucocorticoids and Growth Hormone*

1 reference

12 December 2020

Metabolic effects of steroid withdrawal in adult renal transplant recipients

1 reference

12 December 2020

Inhibition of glucose-stimulated insulin release from beta TC3 cells and rodent islets by an analog of FK506

1 reference

12 December 2020

Short and long term effects of antihypertensive therapy in the diabetic rat

1 reference

12 December 2020

Effect of cyclosporine on glucose metabolism in kidney transplant recipients

1 reference

12 December 2020

Metabolic effects of cyclosporin A and FK 506 in liver transplant recipients

1 reference

12 December 2020

Hyperglycemic nonketotic coma after renal transplantation

1 reference

12 December 2020

10.2165/00002018-199716040-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

30 September 2017

1047526824

0 references

1 reference